Navigation Links
Pfizer Contributes Critical Data to URMC Drug Safety Initiative
Date:1/12/2009

ROCHESTER, N.Y., Jan. 12 /PRNewswire-USNewswire/ -- Pfizer Inc. has agreed to provide the University of Rochester Medical Center (URMC) with a unique set of electrocardiographic data that will help researchers develop new methods to ensure the safety of experimental drugs. This is the first time a major pharmaceutical company has agreed to publicly share anonymous data from one of its drug safety trials, including data from the drug that was being evaluated.

Pfizer Global Research and Development's Sandwich Laboratory in the United Kingdom is releasing a large set of continuous electrocardiographic (ECG) recordings to URMC from which more than 1.5 million individual ECGs datasets can be extracted.

A full set of study data, which Pfizer is providing, is extremely valuable because it enables scientists to evaluate the electrical activity in the heart before and after study participants took the drug and compare that data to study subjects who received a placebo or a control drug that is known to prolong the repolarization process.

Earlier this year, URMC announced that it was collaborating with the U.S. Food and Drug Administration (FDA) to develop a national repository of data that will aid academic and industry researchers studying the electrical activity of the heart. The resulting database, called the Telemetric and Holter ECG Warehouse (THEW), consists of a digital catalogue of continuous recordings from both cardiac patients and healthy individuals and is available to academic researchers, pharmaceutical companies, contract research organizations, device manufacturers, and other interested parties.

The Pfizer data, in compliance with international privacy laws, has been fully anonymized, or stripped of any information that would enable individual patients to be identified. Additionally, the THEW was designed in order to comply with ethics and patient privacy laws; all dat
'/>"/>

SOURCE University of Rochester Medical Center
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Medarex Receives Milestone Payment from Pfizer for Investigational New Drug Application Filing
2. Silence Therapeutics to Receive $1.9m Milestone Payment as Pfizer and Quark Commence Phase II Trial
3. Quark Pharmaceuticals Announces First Patient Dosing by Pfizer in Phase II Trial of RNAi Therapy in Diabetic Macular Edema
4. MannKind Addresses Pfizers Announcement Regarding Exubera
5. Tacere Therapeutics Enters Collaboration and License Agreement With Pfizer To Develop and Commercialize RNAi Hepatitis C Drug
6. NicOx Announces Pfizer Initiates Phase 2 Clinical Development for PF-03187207 in Japan
7. Rigel Announces Initiation of Phase 1 Clinical Trial of R343 for Allergic Asthma by its Partner Pfizer
8. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
9. Kosans Motilin Receptor Agonist, Licensed to Pfizer, Enters Phase 1 Clinical Trial in Gastroesophageal Reflux Disease
10. Wyeths Torisel and Roche/Genentechs Avastin Will Challenge Pfizers Sutent to Become the Clinical Gold Standard for Treatment of Metastatic Renal Cell Carcinoma
11. Critical Pharmaceuticals Enter Sustained Release hGH Arena
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SAN DIEGO , Aug. 29, 2014 /PRNewswire/ ... an emerging biopharmaceutical company, announced today that Santosh ... will be leaving the Company, for personal reasons, ... the Chief Medical Officer of Aires Pharmaceuticals, which ... Vetticaden,s former responsibilities as the Company,s interim Chief ...
(Date:8/29/2014)... -- Research and Markets has announced the ... 2014-2017" report to their offering. ... reimbursement for medical expenses, the Chinese orthopedic instrument market ... a CAGR of 19.2% during 2009-2013. Trauma products, spine ... orthopedic instruments in China , of ...
(Date:8/29/2014)... DENVER , Aug. 29, 2014 Does your ... date, nearly 800 doctors have recommended marijuana to the over ... Amendment 20. But the majority of the other roughly 20,300+ ... still know very little about it – even though a ... adults say they have tried it. ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... , PITTSBURGH , Feb. 4 ... was sued by Pfizer in connection with the filing of an ... Administration (FDA) for Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10 mg, ... mg, 10/10 mg, 10/20 mg, 10/40 and 10/80 mg. This product ...
... Calif. , Feb. 4 Imagine having to ... medications a day to manage a chronic health condition; add ... incorrectly. For Anthem Blue Cross (Anthem) Medi-Cal members, that daily ... and reduce medication errors. , Anthem will now offer ...
Cached Medicine Technology:Mylan Confirms First-to-File Patent Challenge Relating to Caduet(R) 2Medi-Cal Members Reduce Potential for Medication Error with Innovative Program 2Medi-Cal Members Reduce Potential for Medication Error with Innovative Program 3
(Date:8/30/2014)... New York, NY (PRWEB) August 30, 2014 ... headlines will quickly ensue, as happened on Wednesday, August 27th, ... a successful attack on JPMorgan Chase & Co and ... that the FBI is actually investigating attacks on seven ... and how they may be affected, and the buzz quickly ...
(Date:8/30/2014)... As 500 Zoloft lawsuits pending ligation contend the SSRI andidepressant ... & Schulte LLC recently learned of a remand issued by ... in the Zoloft lawsuits was granted to 25 plaintiffs ... one SSRI lawsuit filed jointly under MDL 2342 ... sent back to the Missouri state court in which it ...
(Date:8/30/2014)... 30, 2014 Barton Associates, an industry ... tenens company , announces a new office location in ... Associates is headquartered in Peabody, MA, with additional staffing ... TX; and Jupiter, FL. , Barton Associates made the ... physician shortage crisis affecting the United States, a crisis ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: The first ... patients with acute coronary syndromes (ACS) are published ... position paper was written jointly by the European ... Association (ACCA) and the European Association of Percutaneous ... , Professor Bulent Gorenek (Turkey), chairperson of the ...
(Date:8/30/2014)... Spain Saturday 30 August 2014: A new ... (HCM) identifies candidates for implantable cardioverter defibrillators (ICDs) ... at ESC Congress by Task Force Chairperson Professor ... on Diagnosis and Management of Hypertrophic Cardiomyopathy" are ... Journal (1) and on the ESC Website. ...
Breaking Medicine News(10 mins):Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 2Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 3Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 4Health News:Big Name Bank Hacks Highlight the Importance of Regular Testing and Effective Emergency Response 5Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 2Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 3Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 4Health News:Group of Plaintiffs in Zoloft Lawsuit Alleging SSRI Caused Birth Defect Are Granted Remand 5Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:First multidisciplinary recommendations on management of arrhythmias in ACS patients 2Health News:Sudden death predictor identifies ICD candidates in new ESC Guidelines 2
... ... to help anyone seeking improved health and wellness. Learn how to improve the look and ... enhance your physical appearance with information provided on this new Web site. , ... (PRWEB) June 17, 2010 -- A new Web site has ...
... , ... to announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives ... ... announce the addition of Lázaro Garza as an Engineered Sales Representative for Ellsworth Adhesives S. ...
... Italy, Thursday 17 June 2010: Smoking cigarettes is a ... may have a negative impact on the effectiveness of ... these treatments, according to results of two studies presented ... European League Against Rheumatism in Rome, Italy. A further ...
... ... in 2010 Focusing on Professional, Olympic, and Recreational Athletes , ... Washington, D.C. (PRWEB) June 17, 2010 -- Athletes for Hope ... Agassi, Muhammad Ali, and Lance Armstrong for the purpose of inspiring all athletes to engage ...
... ... Receives Seal of Approval from Industry Voice , ... Fishkill, NY (PRWEB) June 17, 2010 -- Dear ... dentistry and oral health, has announced that the International Congress of Oral Implantologists ...
... ... released Semantics Platform v 2.0 which is made up of three products: Semantics.Datacenter, Semantics.Server, ... product offerings in industry standard benchmark tests (Berlin 100M 5/25/10). , ... Brattleboro, VT (PRWEB) June ...
Cached Medicine News:Health News:New Web Site Provides Helpful Exercise and Nutrition Tips 2Health News:Ellsworth Adhesives Announces New International Engineered Sales Representative 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 2Health News:Smoking cigarettes is a predictor of RA and may negatively impact on efficacy of anti-TNFs 3Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 2Health News:Athletes for Hope Awarded $2 Million Grant by Kellogg Foundation 3Health News:International Congress of Oral Implantologists (ICOI) Joins Other Professional Organizations Endorsing Dear Doctor Magazine 2Health News:Intellidimension Releases New Version of Semantic Web Technologies 2
... HIBICLENS bonds with the ... protective, germ-killing field. In ... acting antimicrobial effect, HIBICLENS' ... potential promotes compliance with ...
... solution, allows the user to prep one ... in less than 2-minutes. It also utilizes ... surgical scrubbing and healthcare personnel handwashing. ACTIPREP ... provide a tacky surface for drapes to ...
... This multi-purpose topical gel contains 10% Povidone ... germicidal action. As a pre-operative prep, Povidone ... of prepping solutions under the patient, thus ... Gel is also approved as a one ...
... Scrub is a gentle and effective surgical ... dryness. Povidone Iodine is known to kill ... bacteria, fungi, viruses, protozoa and yeasts. It ... step in patient pre-operative prepping, as well ...
Medicine Products: